合成路线1
该中间体在本合成路线中的序号:
(XIV) The condensation of diethyl succinate (IX) with benzaldehyde (II) gives 2-benzylidenesuccinic acid (III), which is treated with refluxing Ac2O to yield the corresponding anhydride (IV). Reaction of (IV) with cis-perhydroisoindole (V) in toluene affords the monoamide (VI), which is reduced with H2 over Pd/C in ethanol to provide the racemic benzylsuccinamic acid (X). Esterification of (X) with (S)-N-benzylmandelamide (XI) by means of DCC and DMAP in dichloromethane gives a mixture of diastereomeric esters, which were separated by column chromatography on silica gel to provide the desired diastereomer (XII). The hydrolysis of (XII) with NaOH in methanol yields the chiral acid (XIII), which is finally treated first with NaOH and then with CaCl2 in water.
The preceding optical resolution of racemic acid (X) can also be performed with (R)-1-phenylethylamine (VII) or (R)-1-(1-naphthyl)ethylamine (XIV) by fractional crystallization of the corresponding diastereomeric salts and treatment with 2N HCl.
【1】
Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034.
|
【2】
Yamaguchi, T.; et al.; Preparation of optically active succinic acid derivatives. I. Optical resolution of 2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionic acid. Chem Pharm Bull 1997, 45, 9, 1518.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(III) |
41057 |
2-[(Z)-benzylidene]succinic acid
|
|
C11H10O4 |
详情 |
详情
|
(IV) |
41058 |
3-[(Z)-benzylidene]-2,5(4H)-furandione
|
|
C11H8O3 |
详情 |
详情
|
(V) |
41059 |
(3aR,7aS)octahydro-1H-isoindole
|
|
C8H15N |
详情 |
详情
|
(VI) |
41060 |
(Z)-2-[2-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-oxoethyl]-3-phenyl-2-propenoic acid
|
|
C19H23NO3 |
详情 |
详情
|
(VII) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
(IX) |
12313 |
diethyl succinate
|
123-25-1 |
C8H14O4 |
详情 | 详情
|
(X) |
41062 |
4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid
|
|
C19H25NO3 |
详情 |
详情
|
(XI) |
41063 |
(2S)-N-benzyl-2-hydroxy-2-phenylethanamide
|
|
C15H15NO2 |
详情 |
详情
|
(XII) |
41065 |
(1S)-2-(benzylamino)-2-oxo-1-phenylethyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate
|
|
C34H38N2O4 |
详情 |
详情
|
(XIII) |
41064 |
(2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid
|
|
C19H25NO3 |
详情 |
详情
|
(XIV) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(XIV) The optical resolution of racemic 2-benzylsuccinic acid (XV) using the chiral amines (R)-1-phenylethylamine (VII), (R)-1-(1-naphthyl)ethylamine (XIV) or (S)-1-phenyl-2-(4-tolyl)ethylamine (XVI) is carried out by fractional crystallization of the corresponding diastereomeric salts and treatment with 2N HCl, providing the desired enantiomer 2(S)-benzylsuccinic acid (XVII). Reaction of (XVII) with SOCl2 gives the corresponding acyl chloride (XVIII), which is treated with 4-nitrophenol (XIX) and TEA in dichloromethane to yield the activated diester (XX). The regioselective reaction of (XX) with cis-perhydroisoindole (V) in dichloromethane affords the monoamide (XXI), which by reaction with HCl and methanol provides the corresponding methyl ester (XXII). This ester is hydrolyzed with NaOH to the previously described chiral succinamic acid (XIII), which is finally converted into its calcium salt.
【1】
Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034.
|
【2】
Mukaiyama, Y.; Hokari, H.; Kamijo, T.; Yanagi, T.; Yamaguchi, T.; Yamamoto, I.; Preparation of optically active succinic acid derivatives. II. Efficient and practical synthesis of KAD-1229. Chem Pharm Bull 1998, 46, 2, 337-340.
|
【3】
Yamaguchi, T.; et al.; Synthesis of KAD-1229, a succinic acid derivative with optical activity. 118th Annu Meet Pharmaceut Soc Jpn (March 31 1998, Kyoto) 1998, Abst 31(XP)9-9.
|
【4】
Yamaguchi, T.; Kamijo, T.; Yanagi, T. (Kissei Pharmaceutical Co., Ltd.); Process for producing optically active benzylsuccinic acid and intermediate therefor. WO 9832727 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
41059 |
(3aR,7aS)octahydro-1H-isoindole
|
|
C8H15N |
详情 |
详情
|
(VII) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
(XIII) |
41064 |
(2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid
|
|
C19H25NO3 |
详情 |
详情
|
(XIV) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(XV) |
41066 |
2-benzylsuccinic acid
|
|
C11H12O4 |
详情 |
详情
|
(XVI) |
41067 |
(1S)-2-(4-methylphenyl)-1-phenylethylamine; (1S)-2-(4-methylphenyl)-1-phenyl-1-ethanamine
|
30339-30-1 |
C15H17N |
详情 | 详情
|
(XVII) |
41068 |
(2S)-2-benzylbutanedioic acid
|
|
C11H12O4 |
详情 |
详情
|
(XVIII) |
41069 |
(2S)-2-benzylbutanedioyl dichloride
|
|
C11H10Cl2O2 |
详情 |
详情
|
(XIX) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(XX) |
41070 |
bis(4-nitrophenyl) (2S)-2-benzylbutanedioate
|
|
C23H18N2O8 |
详情 |
详情
|
(XXI) |
41071 |
4-nitrophenyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate
|
|
C25H28N2O5 |
详情 |
详情
|
(XXII) |
41072 |
methyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate
|
|
C20H27NO3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XXIX) 3) The condensation of 3-(trimethylsilyl)propynal (XXIII) with the dialkaline salt of ethylacetoacetate (XXIV) in THF gives 5-hydroxy-3-oxo-7-(trimethylsilyl)-6-heptynoic acid ethyl ester (XXV), which is reduced with NaBH4/diethylmethoxyborane to the racemic 3,5-dihydroxy-7-(trimethylsilyl)-6-heptynoic acid ethyl ester (XXVI). The protection and desilylation of (XXVI) with 2,2-dimethoxypropane and p-toluenesulfonic acid yields the protected heptynoic ester (XXVII), which is saponified to the corresponding acid (XXVIII) with NaOH. The optical resolution of the racemic acid (XXVIII) by treatment with 1(R)-(1-naphthyl)ethylamine (XXIX) and crystallization of the diastereomeric salts affords the protected (3R,5S)-isomer (XXX), which is esterified with ethyl iodide and DBU to the corresponding ester (XXXI). The condensation of (XXXI) with 2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline (XXI, see Scheme 5) by means of disiamylborane, NaOEt and PdCl2 in acetonitrile gives the protected (3R,5S)-NK-104 ethyl ester (XXXII).
【1】
Castaner, J.; Sorbera, L.A.; Leeson, P.A.; NK-104. Drugs Fut 1998, 23, 8, 847-859.
|
【2】
Iwasaki, H.; Miyachi, N.; Yanagawa, Y.; Ohara, Y.; Hiyama, T.; A novel synthetic method of HMG-CoA reductase inhibitor NK-104 via a hydroboration-cross-coupling sequence. Tetrahedron Lett 1993, 34, 51, 8267-70.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXI) |
17435 |
2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline
|
|
C18H13FIN |
详情 |
详情
|
(XXIII) |
17437 |
2-butynal
|
|
C4H4O |
详情 |
详情
|
(XXIV) |
17438 |
lithium sodium (1E)-1-ethoxy-1,3-butadiene-1,3-diolate
|
|
C6H8LiNaO3 |
详情 |
详情
|
(XXV) |
17439 |
ethyl 5-hydroxy-3-oxo-7-(trimethylsilyl)-6-heptynoate
|
|
C12H20O4Si |
详情 |
详情
|
(XXVI) |
17440 |
ethyl 3,5-dihydroxy-7-(trimethylsilyl)-6-heptynoate
|
|
C12H22O4Si |
详情 |
详情
|
(XXVII) |
17441 |
ethyl 2-(6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
|
|
C12H18O4 |
详情 |
详情
|
(XXVIII) |
17442 |
2-(6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid
|
|
C10H14O4 |
详情 |
详情
|
(XXIX) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(XXX) |
17444 |
2-[(4R,6S)-6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid
|
|
C10H14O4 |
详情 |
详情
|
(XXXI) |
17445 |
ethyl 2-[(4R,6S)-6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate
|
|
C12H18O4 |
详情 |
详情
|
(XXXII) |
17446 |
ethyl 2-((4R,6S)-6-[(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxan-4-yl)acetate
|
|
C30H32FNO4 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(XXIX) Reaction of chloroacetic acid (XXII) with sodium ethoxide (XXIII) in ethanol gives 2-ethoxyacetic acid ethyl ester (XXIV), which is condensed with 4-methoxybenz-aldehyde (XXV) by means of t-BuOK in THF to yield 2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid ethyl ester (XXVI). Hydrolysis of ester (XXVI) with NaOH in hot ethanol/water affords the propenoic acid derivative (XXVII), which is reduced with H2 over Pd/C in ethanol to provide racemic 2-ethoxy-3-(4-methoxyphenyl)propionic acid (XXVIII). Optical resolution of mixture (XXVIII) is performed by salt formation with 1(S)-(1-naphthyl)ethylamine (XXIX) followed by crystallization to give the diastereomeric salt (XXX), which is treated with NaOH, followed by acidification with HCl to yield 2(S)-ethoxy-3-(4-methoxyphenyl)propionic acid (XXXI). Demethylation of compound (XXXI) by reaction with NaOH and octanethiol in NMP affords 2(S)-ethoxy-3-(4-hydroxyphenyl)propionic acid (XXXII), which is esterified with ethanol/HCl to provide the corresponding ethyl ester (XXXIII). Condensation of ester (XXXIII) with the bismesylate (II) by means of either K2CO3 in 2-butanone or Na2CO3 in acetone provides 2(S)-ethoxy-3-[4-[2-[4-(methanesulfonyloxy)-phenyl]ethoxy]phenyl]propionic acid ethyl ester (XXI), which is finally hydrolyzed with NaOH or LiOH in acetone/water.
【1】
McIntyre, J.A.; Castaner, J.; Bayes, M.; Tesaglitazar. Drugs Fut 2003, 28, 10, 959.
|
【2】
Ioannidis, P.; Ehrl, R.; MacKintosh, W. (AstraZeneca AB); Process for the preparation 3-aryl-2-hydroxypropionic acid deriv.. WO 0296865 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
50403 |
4-[2-[(methylsulfonyl)oxy]ethyl]phenyl methanesulfonate
|
|
C10H14O6S2 |
详情 |
详情
|
(XX) |
50418 |
ethyl (2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoate
|
|
C13H18O4 |
详情 |
详情
|
(XXI) |
50419 |
ethyl (2S)-2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propanoate
|
|
C22H28O7S |
详情 |
详情
|
(XXII) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(XXIII) |
63048 |
sodium 1-ethanolate
|
|
C2H5NaO |
详情 |
详情
|
(XXIV) |
63049 |
ethyl 2-ethoxyacetate
|
|
C6H12O3 |
详情 |
详情
|
(XXV) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(XXVI) |
63050 |
ethyl (E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoate
|
|
C14H18O4 |
详情 |
详情
|
(XXVII) |
63051 |
(E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid
|
|
C12H14O4 |
详情 |
详情
|
(XXVIII) |
63052 |
2-ethoxy-3-(4-methoxyphenyl)propanoic acid
|
|
C12H16O4 |
详情 |
详情
|
(XXIX) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(XXX) |
63053 |
(1S)-1-(1-naphthyl)-1-ethanaminium (2S)-2-ethoxy-3-(4-methoxyphenyl)propanoate
|
|
C24H29NO4 |
详情 |
详情
|
(XXXI) |
63054 |
(2S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid
|
|
C12H16O4 |
详情 |
详情
|
(XXXII) |
63055 |
(2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoic acid
|
|
C11H14O4 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) Reaction of 1(R)-(1-naphthyl)ethylamine (I) with 3-[3-(trifluoromethyl)phenyl]propionaldehyde (II) by means of titanium tetraisopropoxide gives the corresponding imine (III), which is finally reduced with NaBH3CN in ethanol.
【1】
Bayes, M.; Castaner, R.M.; Sorbera, L.A.; Cinacalcet Hydrochloride. Drugs Fut 2002, 27, 9, 831.
|
【2】
Moe, S.T.; Balandrin, M.F.; Van Wagenen, B.C.; Nemeth, E.F.; DelMar, E.G. (NPS Pharmaceuticals, Inc.); Calcium receptor-active cpds.. US 6211244 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(II) |
55375 |
3-[3-(trifluoromethyl)phenyl]propanal
|
|
C10H9F3O |
详情 |
详情
|
(III) |
55376 |
N-[(1R)-1-(1-naphthyl)ethyl]-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}amine; (1R)-1-(1-naphthyl)-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}-1-ethanamine
|
|
C22H20F3N |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(III)
【1】
Van Wagenen BC.Moe ST,et aL 2001.Pteparationof l-arldethyttunines as.calcium receptor ligands US 6211244 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66202 |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPIONITRILE |
95096-06-3 |
C10H8F3N |
详情 | 详情
|
(II) |
66203 |
(E)-di-tert-butyl((3-(3-(trifluoromethyl)phenyl)propylidene)amino)aluminum |
|
C18H27AlF3N |
详情 | 详情
|
(III) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(IV) |
55376 |
N-[(1R)-1-(1-naphthyl)ethyl]-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}amine; (1R)-1-(1-naphthyl)-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}-1-ethanamine
|
|
C22H20F3N |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VII)
【1】
Lifshitz Liron R. Eisenstadt A, et aL 2006. Process for preparing cinacalcet from 3-(3-trifluoromethylphenyl) propanol. W0 2006125026 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
66204 |
3-(3-(trifluoromethyl)phenyl)propan-1-ol |
|
C10H11F3O |
详情 | 详情
|
(I) |
26348 |
1-bromo-3-(trifluoromethyl)benzene; 3-Bromobenzotrifluoride
|
401-78-5 |
C7H4BrF3 |
详情 | 详情
|
(II) |
10164 |
ethyl acrylate
|
140-88-5 |
C5H8O2 |
详情 | 详情
|
(III) |
42936 |
ethyl (E)-3-[3-(trifluoromethyl)phenyl]-2-propenoate
|
113048-68-3 |
C12H11F3O2 |
详情 | 详情
|
(IV) |
42937 |
(E)-3-[3-(trifluoromethyl)phenyl]-2-propen-1-ol
|
|
C10H9F3O |
详情 |
详情
|
(VI) |
66205 |
3-(3-(trifluoromethyl)phenyl)propyl methanesulfonate |
|
C11H13F3O3S |
详情 | 详情
|
(VII) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|